Use of circulating tumour cells as a prognostic or predictive marker
20 Oct 2011
Use of circulating tumour cells as a prognostic or predictive marker
Advances in the treatment of rectal cancer
Key gastrointestinal cancer research from EMCC 2011
Aflibercept vs placebo and FOLFIRI for MCRC
Roundup of the EMCC 2011 conference
Genetic mutations as causes of cancer
The P-Medicine project; data sharing and integration for personalised medicine
Association of diabetes and cancer epidemiology
Future for immunotherapies
ASCO 2011 highlights
Image-guided radiotherapy for liver metastases spares healthy liver
President-elect of ESTRO